Supplementary Data from Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer

Authors:
  • TNTakako Eguchi Nakajima
    Takako Eguchi Nakajima
  • SKShigenori Kadowaki
    Shigenori Kadowaki
  • KMKeiko Minashi
    Keiko Minashi
  • TNTomohiro Nishina
    Tomohiro Nishina
  • TYTakeharu Yamanaka
    Takeharu Yamanaka
  • YHYuichiro Hayashi
    Yuichiro Hayashi
  • NINaoki Izawa
    Naoki Izawa
  • KMKei Muro
    Kei Muro
  • TKTakeshi Kajiwara
    Takeshi Kajiwara
  • YKYutaka Kawakami
    Yutaka Kawakami

Abstract
Table S1, Table S2, Figure S1 (A)(B)(C)(D)and Figure S2(A)(B)